- Quick takes on 2026 industry-level benchmarks and how they influence framing of competitive intelligence analyses
- How the industry is increasingly “failing early” and what this means for interpreting your competitor’s pipelines
- The practical value of moving from an industry-wide number down to a named-competitor view at the therapeutic area and/or indication level
Join them on October 13th for a practical session on getting more from productivity data.